Genentech is a renowned brand that offers a range of innovative medicines and healthcare solutions. With a strong focus on oncology, Genentech aims to provide patients with effective treatments and improve their quality of life. They offer a diverse portfolio of medicines, including Valcyte® (valganciclovir hydrochloride), which plays a crucial role in managing certain medical conditions.

In addition to their product offerings, Genentech is committed to patient support and education. They have established the Genentech Patient Foundation, which provides financial assistance and resources to help patients access their medicines. They also conduct clinical trials to advance medical research and offer financial support programs for patients.

With a patient-centric approach, Genentech believes in giving patients a voice and empowering them with disease education. They work closely with healthcare professionals to ensure the delivery of high-quality patient care. Genentech is recognized for its leadership in the field of oncology and has received numerous awards and recognition for its contributions to the healthcare industry.

Committed to diversity, inclusion, and sustainability, Genentech actively fosters belonging and advances inclusive research. Please note that the information provided here is based on the scraped HTML and may not represent the most up-to-date details. For the latest information, please refer to Genentech's official website